SynBioVen — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Eden Bioeden.bioNov 2022
Eden Bio develops machine-learning technology for genetic engineering and protein yield optimization across food, pharmaceutical, and biofuel industries.
AI & Machine LearningBiotech
PartnerSir David Harding· solo GP
Co-investorsUnruly CapitalSARAS CAPITAL
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.